AJR 2000; 174:209-211
© American Roentgen Ray Society
MR Imaging of Nasal T-Cell/Natural Killer Cell Lymphoma
Ann D. King1,
Kenny I. K. Lei2,
Anil T. Ahuja1,
Wynnie W. M. Lam1 and
Constantine Metreweli1
1
Department of Diagnostic Radiology and Organ Imaging, Faculty of Medicine, The
Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New
Territories, Hong Kong SAR, China.
2
Department of Clinical Oncology, Faculty of Medicine, The Chinese University
of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
SAR, China.
Received March 19, 1999;
accepted after revision June 25, 1999.
Address correspondence to A. D. King.
Abstract
OBJECTIVE. Nasal T-cell/natural killer cell lymphoma is a distinct
clinicopathologic entity derived from natural killer cells. The purpose of the
study was to describe the MR features of this rare nasal cavity tumor and
correlate MR findings with stage of disease.
CONCLUSION. Nasal T-cell/natural killer cell lymphoma frequently
exhibits diffuse invasion of the nasal cavity with necrosis, midline
destruction, and extension into the nasopharynx. These features may be seen in
both early- and late-stage disease.
Introduction
Lymphoma of the nasal cavity is a rare tumor, accounting for only 3%
of all extranodal non-Hodgkin's lymphomas
[1] and 8% of those extranodal
lymphomas localized to the head and neck region
[2]. The tumor cells frequently
express T-cell (T) associated antigens and the natural killer (NK) cell
marker, CD56. These findings have led to the subsequent recognition of a
distinctive lymphoma subtype called nasal T/NK cell lymphoma
[2,
3,
4,
5,
6,
7,
8]. Despite the characteristic
pathologic features of nasal T/NK cell lymphoma, difficulty in the diagnosis
of nasal T/NK cell lymphoma, both clinically and pathologically, is well
recognized. Furthermore, to our knowledge, the MR features of this specific
group of lymphomas have not been described. In this study, we document the MR
appearances of this rare tumor in seven patients.
Subjects and Methods
Eight Chinese patients with histologically proven nasal T/NK cell lymphoma
were referred to our institution between January 1996 and July 1998. Seven of
these patients (five men, two women; age range, 34-63 years; mean, 43 years)
underwent MR imaging at presentation. These seven patients with MR
examinations constituted the study cohort. Six of the seven patients presented
with newly diagnosed primary nasal lymphoma and one presented with relapse
isolated to the nasal cavity 3 years after successful treatment for
nasopharyngeal lymphoma. Images were obtained on a 1.5-T MR unit (Philips
Gyroscan, Eindhoven, the Netherlands) using a head coil (30-cm diameter). All
patients underwent an axial T1-weighted spin-echo sequence (TR/TE, 500/20;
field of view, 22 cm; slice thickness, 4 mm with no interslice gap; and matrix
size, 256 x 202) and a coronal T2-weighted turbo spin-echo sequence
(TR/TE, 2500/100; echo train length, 14; field of view, 22 cm; slice
thickness, 4 mm with no interslice gap; and matrix size, 256 x 202). In
addition, contrast-enhanced T1-weighted spin-echo images were obtained in six
patients in the axial (n = 5) and coronal (n = 6) planes
after a bolus injection of 0.1 mmol/kg of gadolinium dimeglumine using a 512
x 512 matrix. Scans were reviewed by consensus by two radiologists with
knowledge only of the histologic diagnosis. Scans were assessed for tumor
signal characteristics, site, volume, and local extent; bone and nasal
turbinate destruction; and regional nodes. The MR findings were correlated
with the stage of disease.
Endoscopic examination of the nasal cavity, nasopharynx, oropharynx,
hypopharynx, and upper aerodigestive tract was performed on all patients.
Histologic evaluation and immunohistochemical studies were performed on the
biopsy specimens obtained from the tumor. The diagnosis of nasal T/NK cell
lymphoma was based on the criteria described by Jaffe et al.
[7]. All patients were staged
according to the Ann Arbor system
[9] with modification for
extranodal lymphoma. Clinical staging procedures included complete history and
physical examination; complete blood count; blood chemistry studies; serum
lactate dehydrogenase level; plain chest radiograph; CT scans of the head,
neck, abdomen, and pelvis; and bone marrow aspiration and biopsy. CT of the
thorax was performed only after a patient's chest radiograph showed
abnormalities. None of the patients underwent a staging laparotomy or
lymphangiography.
Results
The patients' symptoms at presentation included nasal blockage (n
= 5), nasal discharge (n = 5), nasal swelling (n = 2),
weight loss (n = 2), fever (n = 2), epistaxis (n =
1), and sore throat (n = 1). Nasal cavity lymphomas were of low to
intermediate signal intensity. On T1-weighted images tumors were of
homogeneous signal intensity similar or slightly higher than that of the
signal intensity of muscle. On T2-weighted images the signal intensity was
higher than that of muscle but lower than that of sinonasal mucosa, and was
homogeneous in six patients and heterogeneous in one patient in whom the tumor
displayed superimposed areas of lower and higher signal intensity. All the
tumors in the six patients who received an injection of gadolinium showed
moderate enhancement that was greater than that of muscle but less than that
of sinonasal mucosa.
There was involvement of both sides of the nasal cavity in five patients
and unilateral involvement in two. In the 12 sides of the nasal cavities with
disease, tumor was small and localized to one region (n = 2),
moderate and localized to more than one region (n = 2), or involved
the entire nasal cavity (n = 8). Tumor volume ranged from 5 to 50
cm3 with a mean of 18 cm3. Sites of extension outside
the nasal cavity included tumor extension into the nasopharynx (n =
4), oropharynx (n = 1), paranasal sinuses (n = 3), and
palate (n = 1). Of the seven patients, three tumors showed areas of
necrosis. There was destruction of the nasal turbinates (n = 4),
nasal septum (n = 4), and hard palate (n = 1). There was no
regional lymphadenopathy The stage of disease was IE, single
extranodal organ or site (n = 6); and stage IVE, diffuse
or disseminated involvement of one or more distant extranodal sites with or
without associated lymph node involvement (n = 1). The one patient
with stage IVE disease had disseminated disease to the bone marrow.
Large-volume tumors involving both sides of the nasal cavity with extranasal
extension, necrosis, and destruction of the nasal turbinates and bone were
found in both stages IE and IVE.
Discussion
Non-Hodgkin's lymphomas of the nasal cavity and nasopharynx are uncommon
tumors. Nearly half (45%) of all malignant lymphomas of the nasal cavity and
nasopharynx are derived from T/NK cells while 21% are derived from T cells and
34% from B cells [10]. The
nasal T/NK cell lymphomas are rare among Western populations but more common
in those of Asian descent [4,
5] and are highly associated
with Epstein-Barr viral infection
[5]. The disease may present
clinically as a lethal midline granuloma or midfacial destructive lesion
[3,
4] and is known for its
predilection for other extranodal sites such as the skin and gastrointestinal
tract, highly aggressive course, and poor prognosis
[7,
10]. Nasal T/NK cell lymphoma
is a distinct clinicopathologic entity with a characteristic immunophenotypic
profile of CD2+, CD56+ (natural killer cell marker) and
CD3-. The tumor often shows polymorphic lymphoreticular infiltrates
and necrosis [11].
Angiocentricity is seen in about half of all cases but is also found in other
lymphoma subtypes. In the past the identification of an underlying lymphoma
was extremely difficult and many of these cases would have been labelled as
polymorphic reticulosis or midline granuloma
[12]. Diagnosis is confused
further by the large array of other diseases with signs and symptoms that may
partly overlap with those of nasal T/NK cell lymphoma. These include malignant
midline granuloma, Stewart's granuloma, progressive lethal granulomatous
ulceration, malignant midline reticulosis, angiocentric immunoproliferative
lesion, and angiocentric lymphoma
[13].
In this study, the nasal T/NK cell lymphomas were of intermediate signal
intensity on T1- and T2-weighted images
(Figs. 1 and
2). The intermediate signal is
common for many malignant tumors of the head and neck and contrasts to the
very hyperintense signal intensity on T2-weighted images that is found almost
exclusively in benign membrane and mucosal diseases. Nasal T/NK cell lymphomas
in this study showed a predilection for diffuse invasion of the nasal cavity
(Fig. 1), often involving both
sides. Even in the smaller volume lymphomas there was a tendency to spread as
a diffuse thin sheet of tumor along the walls of the nasal cavity to envelop
the nasal turbinates and nasal septum (Fig.
2). In larger volume disease a more discernible mass was seen with
destruction of the underlying nasal turbinates
(Figs. 3 and
4). Midline destruction of the
nasal septum occurred in half of the patients
(Fig. 4) and involved the
palate in one patient. Destruction of the lateral wall of the nasal cavity was
not seen, although in one patient the lymphoma caused bowing of the nasal wall
into the maxillary antrum. Tumor necrosis, which is a typical histologic
feature of nasal T/NK cell lymphoma
[7], was shown on MR imaging in
all but one of the patients with a tumor volume of greater than 15
cm3 (Figs. 3 and
4).

View larger version (134K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1 63-year-old man with nasal T-cell and natural killer cell (T/NK)
lymphoma. Axial T1-weighted MR image (TR/TE, 500/20) reveals T/NK cell
lymphoma (arrows). Tumor is of intermediate signal intensity in left
side of nasal cavity.
|
|

View larger version (153K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2 39-year-old man with nasal T-cell and natural killer cell (T/NK)
lymphoma. Coronal T2-weighted MR image (TR/TE, 2500/100) shows small T/NK cell
lymphoma (arrows) of intermediate signal intensity spreading
diffusely along walls of nasal cavity to envelope nasal turbinates.
|
|

View larger version (158K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3 34-year-old woman with nasal T-cell and natural killer cell (T/NK)
lymphoma. Coronal T1-weighted gadolinium-enhanced MR image (TR/TE, 500/20)
shows T/NK cell lymphoma in the right nasal cavity (arrows). Tumor
shows destruction of middle turbinate. Solid superior component of tumor shows
moderate enhancement and inferior component is necrotic.
|
|

View larger version (150K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4 34-year-old man with nasal T-cell and natural killer cell (T/NK)
lymphoma. Coronal T1-weighted gadolinium-enhanced MR image (TR/TE, 500/20)
reveals midline nasal T/NK cell lymphoma (arrows) with destruction of
nasal septum and nasal turbinates. The tumor is predominately necrotic with
thin rim of moderately enhancing solid tissue adjacent to more intensely
enhancing turbinates and sinonasal mucosa.
|
|
The T/NK cell lymphomas were confined to the nasal cavity in two patients.
The remaining five patients had tumor extensions outside the nasal cavity,
most frequently into the nasopharynx. In two of these five patients, a small
volume of tumor extended just beyond the nasal cavity into one wall of the
nasopharynx. Two patients showed invasion of a wider area of the nasopharynx,
and in the fifth patient the lymphoma extended inferiorly into the oropharynx.
Invasion of the paranasal sinuses was less common and of smaller volume when
compared with those invading into the nasopharynx and oropharynx. Tumor
extension superiorly through the cribriform plate into the cranium was not
seen. Regional nodal disease was not identified in this study. This was to be
expected because nodal involvement in nasal T/NK cell lymphoma is rare and
more commonly associated with the B-cell lymphomas
[10].
The diagnosis of nasal T/NK-cell lymphoma requires histologic evidence. MR
features alone cannot reliably distinguish this tumor from other nasal cavity
tumors such as squamous cell carcinoma, minor salivary gland tumor,
esthesioneuroblastoma, rhabdomyosarcoma, and lymphoepithelioma. In particular,
the aggressive carcinomas, such as adenocarcinoma and undifferentiated
carcinoma, can show a similar low to intermediate signal intensity on T1- and
T2-weighted images [14] and
they are frequently accompanied by bone destruction
[15]. Nonneoplastic conditions
including Wegener's granulomatosis, sarcoidosis, cocaine abuse, and infections
such as leprosy, syphilis, tuberculosis, and fungus may also cause midfacial
destruction. However, the differential diagnosis relies more on clinical and
laboratory findings than radiologic findings.
In accordance with the literature, most of the patients with nasal NK/T
cell lymphomas in this study presented at an early stage with nearly 90%
classified as stage IE
[5]. Disseminated disease
carries a poorer prognosis and was present in one patient (stage
IVE). The patient with disseminated disease showed a large-volume
necrotic bilateral nasal cavity tumor extending into the paranasal sinuses and
nasopharynx with extensive destructive changes in the nasal septum and palate.
However, large-volume disease accompanied by necrosis, bone destruction, or
extranasal disease was also found in patients with early stage I disease. This
limited sample suggests that there may be a disparity between the severity of
the radiologic findings and the stage of disease. Further studies will be
required to determine the correlation between the extent of tumor, degree of
tissue destruction, and tumor volume revealed by MR imaging and the various
clinical characteristics, disease stage, and, ultimately, clinical
outcome.
In conclusion, patients with nasal T/NK cell lymphoma frequently present
with only localized disease. The MR imaging appearance is nonspecific and
diagnosis requires histologic confirmation. However, the predilection for T/NK
cell lymphoma to cause a diffuse necrotic mass that spreads to the nasopharynx
with destruction of the midline structuresthe nasal turbinates, nasal
septum and palateare features that in an Asian patient should suggest
the diagnosis of nasal T/NK cell lymphoma.
References
-
Ho FCS, Todd D, Loke SL, Ng RP, Khoo RKK. Clinico-pathological
features of malignant lymphomas in 294 Hong Kong Chinese patients,
retrospective study covering an eight-year period. Int J Cancer
1984;34:143-148[Medline]
-
Hanna E, Wanamaker J, Adelstein D, Tubbs R, Lavertu P. Extranodal
lymphomas of the head and neck: a 20-year experience. Arch Otolaryngol
Head Neck Surg
1997;123:1318-1323
-
Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/nasopharyngeal
lymphomas are peripheral T-cell lymphomas. Am J Surg Pathol
1987;11:418-429[Medline]
-
Weiss LM, Arber DA, Strickler JG. Nasal T-cell lymphoma. Ann
Oncol
1994;10:39-42[Abstract/Free Full Text]
-
Kwong YL, Chan ACL, Liang R, et al. CD56+ NK lymphomas:
clinicopathological features and prognosis. Brit J Haematol
1997;4:821-829
-
Chan JKC. Peripheral T and natural killer cell lymphomas. Am
J Surg Pathol
1997;21:118-119
-
Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal
and related extranodal angiocentric T/natural killer cell lymphomas:
definitions, differential diagnosis, and epidemiology. Am J Surg
Pathol
1996;20:103-111[Medline]
-
Jaffe ES. Classification of natural killer (NK) cell and NK-like
T-cell malignancies (editorial). Blood
1996;87:1207-1210[Free Full Text]
-
Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report
of the committee on Hodgkin's disease classification. Cancer
Res
1971;31:1860-1861[Free Full Text]
-
Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma
of the nose and nasopharynx: clinical features, tumor immunophenotype, and
treatment outcome in 113 patients. J Clinical Oncol
1998;16:70-77[Abstract/Free Full Text]
-
Ferry JA, Sklar J, Zukerberg LR, Harris NL. Nasal lymphoma. A
clinicopathologic study with immunophenotypic and genotypic analysis.
Am J Surg Pathol
1991;15:268-279[Medline]
-
Eichel BS, Harrison EG, Devine KD, Scanlow PW, Brown HA. Primary
lymphoma of the nose including a relationship to lethal midline granuloma.
Am J Surg
1966;112:597-605[Medline]
-
Chan JK. Natural killer cell neoplasms. Anat Pathol
1998;3:77-145[Medline]
-
Som PM, Shapiro MD, Biller HF, Sasaki C, Lawson W. Sinonasal tumors
and inflammatory tissues: differentiation with MR imaging.
Radiology
1988;167:803-808[Abstract/Free Full Text]
-
Phillips CD, Futterer SF, Lipper MH, Levine PA. Sinonasal
undifferentiated carcinoma: CT and MR imaging of an uncommon neoplasm of the
nasal cavity. Radiology
1997;202:477-480[Abstract/Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. M. Kim, Y. H. Park, S.-Y. Lee, J.-H. Kim, D.-W. Kim, S.-A. Im, T.-Y. Kim, C. W. Kim, D. S. Heo, Y.-J. Bang, et al.
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type
Blood,
December 1, 2005;
106(12):
3785 - 3790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Lee, J.-G. Im, J. M. Goo, K. W. Kim, B. I. Choi, K. H. Chang, J. K. Han, and M. H. Han
Peripheral T-Cell Lymphoma: Spectrum of Imaging Findings with Clinical and Pathologic Features
RadioGraphics,
January 1, 2003;
23(1):
7 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|